SCHEMBL1924028

SCHEMBL1924028

Cc1cc(C(=O)CC(=O)C(F)F)ccc1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.39
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 1/20 0.36
PLA2G1B P04054 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX12 P18054 1/20 0.36
CYP2C19 P33261 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
KIF11 P52732 1/20 0.36
MAPT P10636 3/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
PDE2A O00408 1/20 0.36
PTPN1 P18031 1/20 0.36
POLB P06746 1/20 0.35
NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30576197 0.83 GAA (0.50) ALDH1A1MAPTLMNAGAATAS1R3
SCHEMBL9859044 0.82 NOTUM (0.41) NOTUMNPSR1ALDH1A1PLA2G1BCYP1A2
SCHEMBL1349593 0.82 PLOD2 (0.54) NOTUMNPSR1ALDH1A1PLA2G1BCYP1A2
SCHEMBL1348875 0.79 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL23112403 0.78 GSK3B (0.54) NOTUMNPSR1ALDH1A1PLA2G1BCYP1A2
SCHEMBL16911534 0.77 TAS1R3 (0.52) ALDH1A1MAPTLMNAGAATAS1R3
SCHEMBL6722858 0.76 CHRNA1 (0.48) NPSR1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL313060 0.74 PTPN1 (0.62) ALDH1A1MAPTPTPN1PLOD2SRD5A2
SCHEMBL312657 0.74 KIF11 (0.56) NOTUMNPSR1ALDH1A1PLA2G1BCYP1A2
SCHEMBL13916848 0.74 NPC1 (0.58) ALDH1A1PLA2G1BALOX12ATG4BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670801-B1 PYRAZOLO AND IMIDAZO-PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2011-06-08 EP disclosed
US-7514443-B2 Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of metabotropic glutamate receptors HOFFMANN-LA ROCHE INC. (US) 2009-04-07 US disclosed
US-20080051421-A1 Pyrazolo-pyridine WICHMANN JUERGEN 2008-02-28 US disclosed
US-7329662-B2 Pyrazolo-pyridine HOFFMANN-LA ROCHE INC. (US) 2008-02-12 US disclosed
CN-1890242-A Pyrazolo and imidazo-pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2007-01-03 CN disclosed
EP-1670801-A1 PYRAZOLO AND IMIDAZO-PYRIMIDINE DERIVATIVES F. Hoffmann-Roche AG (CH) 2006-06-21 EP disclosed
US-20050130992-A1 Pyrazolo-pyridine F. HOFFMANN-LA ROCHE AG (CH) 2005-06-16 US disclosed
WO-2005040171-A1 PYRAZOLO AND IMIDAZO-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130992-A1 Pyrazolo-pyridine CHRM2, CHRM1, QDPR NOTUM 4036/4885NPSR1 460/4885ALDH1A1 468/4885
US-20080051421-A1 Pyrazolo-pyridine CHRM2, CHRM1, QDPR NOTUM 4036/4885NPSR1 460/4885ALDH1A1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.